{"title":"Prise unique hebdomadaire impérative pour le méthotrexate per os","authors":"","doi":"10.1016/S1769-7344(11)70368-7","DOIUrl":"https://doi.org/10.1016/S1769-7344(11)70368-7","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 27","pages":"Page 7"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70368-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137333060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Évaluation des médicaments et des technologies de santé: Évaluations de l’utilisation de la curiethérapie de bas débit de dose, de systèmes mis en place pour déminuer les erreurs d’administration des médicaments et du rapport coût/efficacité du traitement de l’hépatite B chronique","authors":"Catherine Montagnier-Petrissans","doi":"10.1016/S1769-7344(11)70378-X","DOIUrl":"https://doi.org/10.1016/S1769-7344(11)70378-X","url":null,"abstract":"<div><p>Les trois rapports d’évaluation évoqués dans cet article, dont un sous forme de réponse rapide, proposent de faire le point sur le niveau de preuves dans la littérature internationale sur des sujets différents. Le premier compare l’efficacité et le coût de la curiethérapie de bas débit de dose aux autres types de prise en charge utilisées pour traiter le cancer localisé de la prostate. Le deuxième évalue l’impact des systèmes mis en œuvre pour diminuer les erreurs d’administration des médicaments en unité de soins intensifs. Le troisième compare le rapport coût-efficacité des différents médicaments utilisés pour traiter l’hépatite B chronique.</p></div>","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 27","pages":"Pages 36-45"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70378-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137334742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Une convention-type pour garantir la sécurité du patient en HAD","authors":"Valérie Lequien","doi":"10.1016/S1769-7344(11)70363-8","DOIUrl":"10.1016/S1769-7344(11)70363-8","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 27","pages":"Page 5"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70363-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"99693030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"L’Association française contre les myopathies : un établissement pharmaceutique pas comme les autres","authors":"Aurélie Haroche","doi":"10.1016/S1769-7344(11)70344-4","DOIUrl":"10.1016/S1769-7344(11)70344-4","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Page 6"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70344-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56673307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"La prise en charge des anémies par carence","authors":"Émilie Dubost, Antoine Dupuis","doi":"10.1016/S1769-7344(11)70351-1","DOIUrl":"10.1016/S1769-7344(11)70351-1","url":null,"abstract":"<div><p>Les carences en fer, folates et vitamine B12 sont fréquentes chez l’adulte, notamment chez les personnes âgées, mais elles restent souvent méconnues, voire inexplorées, en raison de manifestations cliniques peu dominantes, dont la principale est la survenue d’une anémie. Néanmoins, la gravité potentielle de leurs complications hématologiques, neuropsychiatriques, cardiovasculaires n’est pas à négliger. À partir des données bibliographiques, cet article fait le point sur les étiologies, le diagnostic et les traitements des carences en fer, en folates et en vitamine B12.</p></div>","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Pages 10-17"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70351-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56673712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"L’arrêté du 6 avril 2011, un texte promis depuis de longs mois sur le management par la qualité de la prise en charge médicamenteuse","authors":"Catherine Montagnier-Petrissans","doi":"10.1016/S1769-7344(11)70338-9","DOIUrl":"10.1016/S1769-7344(11)70338-9","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Page 1"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70338-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113236927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Grossesse VIH+ : nouvelle stratégie de traitement par antiprotéase","authors":"Chantal Bertholom","doi":"10.1016/S1769-7344(11)70339-0","DOIUrl":"10.1016/S1769-7344(11)70339-0","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Page 4"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70339-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56673404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Conduite à tenir devant une augmentation de la ferritine","authors":"Lucile Jeanne","doi":"10.1016/S1769-7344(11)70352-3","DOIUrl":"10.1016/S1769-7344(11)70352-3","url":null,"abstract":"<div><p>Face à une augmentation de la ferritine, il convient de compléter le bilan par le calcul du coefficient de saturation. Si ce dernier est normal, le diagnostic s’orientera principalement vers un syndrome inflammatoire ou une hépatosidérose métabolique. En revanche, s’il est supérieur à 45%, les diagnostics fréquents sont alors maladie alcoolique, hémochromatose génétique HFE-1 et surcharges acquises.</p></div>","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Pages 18-19"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70352-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56673750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anémies par carences martiale et vitaminiques","authors":"Émilie Dubost, Antoine Dupuis","doi":"10.1016/S1769-7344(11)70350-X","DOIUrl":"10.1016/S1769-7344(11)70350-X","url":null,"abstract":"<div><p>L’anémie est un problème de santé relativement fréquent. Selon l’Organisation mondiale de la Santé, 25% de la population mondiale souffre d’anémie. La moitié de ces cas serait attribuable à une carence nutritionnelle en fer. Les femmes qui ont des menstruations abondantes, les enfants d’àge préscolaire et les femmes enceintes sont les plus à risque d’anémie. Selon la nature de la carence responsable d’anémie, il existe différents traitements qui ont pour but de favoriser la reconstitution des érythrocytes dans le sang, ou d’y rétablir les quantités normales d’hémoglobine.</p></div>","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Page 9"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70350-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56673645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Une information aux patients sous dopaminergiques","authors":"","doi":"10.1016/S1769-7344(11)70343-2","DOIUrl":"https://doi.org/10.1016/S1769-7344(11)70343-2","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Page 5"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70343-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138417383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}